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Supplementary Material Table S1: CHEERS Checklist 
Item Recommendation Page 
number 
Title  Identify the study as an economic evaluation or use more 
specific terms such as “cost-effectiveness analysis”, and 
describe the interventions compared.  
 
1 
Abstract  Provide a structured summary of objectives, perspective, 
setting, methods (including study design and inputs), results 
(including base case and uncertainty analyses), and conclusions  
 
2 
Introduction   
Background and 
objectives 
 Provide an explicit statement of the broader context for the 
study.  
Present the study question and its relevance for health policy or 
practice decisions.  
 
4 
Methods   
Target population  Describe characteristics of the base case population and 
subgroups analysed, including why they were chosen  
 
5 
Setting and 
location 
 State relevant aspects of the system(s) in which the decision(s) 
need(s) to be made.  
 
6 
Study perspective  Describe the perspective of the study and relate this to the 
costs being evaluated.  
 
5,6 
Comparators  Describe the interventions or strategies being compared and 
state why they were chosen.  
 
6 
Time horizon  State the time horizon(s) over which costs and consequences 
are being evaluated and say why appropriate  
 
5 
Discount rate  Report the choice of discount rate(s) used for costs and 
outcomes and say why appropriate  
 
9,10 
Choice of health 
outcomes 
Describe what outcomes were used as the measure(s) of benefit in 
the evaluation and their relevance for the type of analysis 
performed  
7,8 
Measurement of 
effectiveness 
Describe fully the design features of the single effectiveness study 
and why the single study was a sufficient source of clinical 
effectiveness data  
8-11 
Measurement and If applicable, describe the population and methods used to elicit n/a 
valuation of 
preference based 
outcomes 
preferences for outcomes.  
Estimating 
resources and costs 
Describe approaches used to estimate resource use associated 
with the alternative interventions. Describe primary or secondary 
research methods for valuing each resource item in terms of its 
unit cost. Describe any adjustments made to approximate to 
opportunity  
10 
Currency, price, 
date and 
conversion 
Report the dates of the estimated resource quantities and unit 
costs. Describe methods for adjusting estimated unit costs to the 
year of reported costs if necessary. Describe methods for 
converting costs into a common currency base and the exchange 
rate  
10 
Choice of model Describe and give reasons for the specific type of decision-
analytical model used. Providing a figure to show model structure 
is strongly recommended  
9,10 
Assumptions Describe all structural or other assumptions underpinning the 
decision-analytical model  
8,9 
Analytical methods Describe all analytical methods supporting the evaluation. This 
could include methods for dealing with skewed, missing, or 
censored data; extrapolation methods; methods for pooling data; 
approaches to validate or make adjustments (such as half cycle 
corrections) to a model; and methods for handling population 
heterogeneity and uncertainty.  
8,9 
Results   
Study parameters Report the values, ranges, references, and, if used, probability 
distributions for all parameters. Report reasons or sources for 
distributions used to represent uncertainty where appropriate. 
Providing a table to show the input values is strongly 
recommended  
9-11 
Incremental costs 
and outcomes 
For each intervention, report mean values for the main categories 
of estimated costs and outcomes of interest, as well as mean 
differences between the comparator groups. If applicable, report 
incremental cost-effectiveness ratios.  
12-13 
Characterising 
uncertainty 
Describe the effects of sampling uncertainty for the estimated 
incremental cost and incremental effectiveness parameters, 
together with the impact of methodological assumptions (such as 
discount rate, study perspective).  
Tables 
4,5 
Characterising 
heterogeneity 
If applicable, report differences in costs, outcomes, or cost-
effectiveness that can be explained by variations between 
subgroups of patients with different baseline characteristics or 
other observed variability in effects that are not reducible by more 
information 
Tables 
4,5 
Discussion   
Study findings, 
limitations, 
generalisability, 
and current 
knowledge 
Summarise key study findings and describe how they support the 
conclusions reached. Discuss limitations and the generalisability of 
the findings and how the findings fit with current knowledge  
14 
Source of funding Describe how the study was funded and the role of the funder in 
the identification, design, conduct, and reporting of the analysis. 
Describe other non-monetary sources of support  
16 
Conflicts of interest Describe any potential for conflict of interest of study contributors 
in accordance with journal policy. In the absence of a journal 
policy, we recommend authors comply with International 
Committee of Medical Journal Editors recommendations.  
17 
 
 
